50 Participants Needed

High-Resolution CT vs. Angiography for Coronary Artery Disease

JS
JL
AO
MO
AO
Overseen ByAysa Ostovaneh, PharmD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart disease (CHD). However, cardiac catheterization is costly and, as an invasive procedure, it is associated with some risk of adverse events, rarely even stroke, myocardial infarction, or death. Recent advances in multi-detector computed tomography angiography (CTA) have allowed rapid, noninvasive coronary artery imaging in patients with suspected CHD. CTA generally yields high accuracy for identifying patients with CHD when compared to cardiac catheterization. However, diagnostic accuracy is reduced in the setting of severe coronary artery calcification and coronary stents due to its inferior spatial resolution compared to cardiac catheterization. Because high-risk patients often have severe coronary calcification or stents, the application of CTA has been particularly limited in this important patient group. Recently, an ultrahigh-resolution CT scanner was released which has shown promise to overcome the limitation of conventional CTA in the setting of severe coronary artery calcification or stents. This ultrahigh-resolution "precision" CT scanner (UHR-CT) contains detector rows with half the width than currently available systems (0.25 mm vs. 0.5 mm) resulting in approximately twice the spatial resolution. The purpose of this investigation is to test the hypothesis that high-resolution CTA is not inferior to the current standard of cardiac catheterization for identifying significant CHD in patients with high-risk characteristics, including severe coronary artery calcification and coronary stents. The investigators propose to enroll 50 patients over 24-30 months in this investigation as part of a multicenter study. Patients referred for cardiac catheterization with known CHD and suspected obstructive coronary artery stenosis will be included. All patients will undergo both cardiac catheterization and UHR-CT for determining significant CHD as defined by coronary functional assessment. The primary end point will be the diagnostic accuracy by area-under-curve (AUC) method for identifying patients with hemodynamically significant CHD.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment High-Resolution CT vs. Angiography for Coronary Artery Disease?

Coronary CT angiography is effective in diagnosing coronary artery disease, especially with newer technology like 64-slice and 320-slice CT scanners, which provide high-quality images and reliable results. It is particularly useful for patients at intermediate risk of coronary artery disease, offering detailed information about the type and amount of plaque in the arteries.12345

Is coronary CT angiography generally safe for humans?

Coronary CT angiography is considered safe when performed by trained professionals, with efforts to minimize radiation exposure. Studies show it is widely used and can be performed with low radiation doses, making it a reliable and safe option for evaluating coronary artery disease.678910

How does CT Angiography differ from other treatments for coronary artery disease?

CT Angiography (CTA) is a non-invasive test that uses advanced imaging technology to create detailed pictures of the coronary arteries, allowing doctors to see blockages or plaque without needing to insert a catheter into the heart. Unlike invasive coronary angiography, CTA can provide more information about the type and amount of plaque in the arteries and is particularly useful for patients at intermediate risk of coronary artery disease.311121314

Research Team

AA

Armin A Zadeh, MD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for adults aged 45-85 with a history of coronary heart disease (CHD), specifically those who have had a stenosis or revascularization, and are suspected to have obstructive coronary artery stenosis. It's not suitable for individuals with certain heart conditions, allergies to iodine contrast media, kidney issues, or uncontrolled heart rhythm problems.

Inclusion Criteria

I am suspected to have a blocked artery and may need a procedure to open it soon.
I have taken a pregnancy test in the last 24 hours and it was negative.
Ability to understand and willingness to sign the Informed Consent Form
See 1 more

Exclusion Criteria

I have had heart surgery in the past.
My kidney function is reduced, with high creatinine or low clearance.
I have had multiple myeloma or an organ transplant.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

Up to 8 weeks
1 visit (in-person)

Imaging

Participants undergo UHR-CT angiography and conventional coronary angiography

Less than 60 days
2 visits (in-person)

Follow-up

Participants are monitored for adverse events and diagnostic accuracy is assessed

30 days
1 visit (in-person)

Treatment Details

Interventions

  • CT Angiography
  • Invasive Coronary Angiography
Trial Overview The study compares ultra-high-resolution CT angiography (UHR-CT) against the standard invasive coronary angiography in detecting significant CHD. Participants will undergo both procedures so researchers can assess if UHR-CT is as accurate as the current gold standard.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: CT AngiographyExperimental Treatment1 Intervention
Research CT angiography.
Group II: Conventional AngiographyActive Control1 Intervention
Standard medical care which includes cardiac catheterization and invasive coronary angiography.

CT Angiography is already approved in European Union, United States, Canada, Japan for the following indications:

🇪🇺
Approved in European Union as Computed Tomography Angiography for:
  • Diagnosis of coronary artery disease
  • Detection of coronary stenosis
🇺🇸
Approved in United States as Computed Tomography Angiography for:
  • Diagnosis of coronary artery disease
  • Detection of coronary stenosis
  • Evaluation of cardiac structure and function
🇨🇦
Approved in Canada as Computed Tomography Angiography for:
  • Diagnosis of coronary artery disease
  • Detection of coronary stenosis
🇯🇵
Approved in Japan as Computed Tomography Angiography for:
  • Diagnosis of coronary artery disease
  • Detection of coronary stenosis

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Canon Medical Systems, USA

Industry Sponsor

Trials
14
Recruited
1,300+

Findings from Research

Coronary angiography is the most reliable method for diagnosing obstructive coronary artery disease and evaluating the effectiveness of treatments like surgery and angioplasty, supported by advancements in technology over the past 5 to 10 years that have improved both safety and diagnostic quality.
Despite the emergence of newer noninvasive imaging techniques such as CT, MRI, and digital echocardiography, they have not significantly impacted the assessment of coronary circulation compared to traditional angiography.
Coronary angiography: a decade of advances.Higgins, CB.[2019]
Coronary CT angiography has shown significant improvements in diagnostic performance for coronary artery disease, especially with advancements from 4-slice to 320-slice CT scanners, offering high spatial and temporal resolution.
Despite its advantages, coronary CT angiography faces challenges such as inferior temporal resolution, motion artifacts, and a tendency for high false positive rates in cases of severe calcification.
Coronary CT angiography: Diagnostic value and clinical challenges.Sabarudin, A., Sun, Z.[2021]
Multi-slice cardiac CT angiography (CTA) offers high sensitivity and specificity for detecting obstructive coronary lesions, making it a valuable non-invasive tool for diagnosing coronary artery disease (CAD).
CTA provides additional insights into the type and extent of atherosclerotic plaque compared to invasive coronary angiography, and it is particularly beneficial for patients at intermediate risk of CAD, while newer scanning protocols help reduce radiation exposure.
What is the role of invasive versus non-invasive coronary angiography in the investigation of patients suspected to have coronary heart disease?Chow, CK., Sheth, T.[2016]

References

Coronary angiography: a decade of advances. [2019]
Coronary CT angiography: Diagnostic value and clinical challenges. [2021]
What is the role of invasive versus non-invasive coronary angiography in the investigation of patients suspected to have coronary heart disease? [2016]
Prognostic value of coronary computed tomography (CT) angiography. [2021]
Technical and clinical aspects of coronary computed tomography angiography. [2019]
Factors influencing the safety of outpatient coronary CT angiography: a clinical registry study. [2022]
Correlation of radiation dose and heart rate in dual-source computed tomography coronary angiography. [2016]
Declining radiation dose of coronary computed tomography angiography: German cardiac CT registry experience 2009-2014. [2018]
One-year outcomes following coronary computerized tomographic angiography for evaluation of emergency department patients with potential acute coronary syndrome. [2016]
Radiation dose at CT coronary angiography: how low can we go? [2016]
11.United Statespubmed.ncbi.nlm.nih.gov
Coronary artery disease: diagnostic accuracy of CT coronary angiography--a comparison of high and standard spatial resolution scanning. [2022]
The comparison of high and standard definition computed tomography techniques regarding coronary artery imaging. [2018]
Evaluate of the effect of low tube voltage on the radiation dosage using 640-slice coronary CT angiography. [2019]
14.United Statespubmed.ncbi.nlm.nih.gov
Influence of irregular heart rhythm on radiation exposure, image quality and diagnostic impact of cardiac computed tomography angiography in 4,339 patients. Data from the German Cardiac Computed Tomography Registry. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security